AVNS: Avanos Medical Inc Financial Statements

Balance sheet, income statement, and cash flow statements for Avanos Medical Inc (AVNS).

OverviewDividends

$731.64M Market Cap.

As of 05/06/2025 5:00 PM ET (MRY) • Disclaimer

AVNS Market Cap. (MRY)


AVNS Shares Outstanding (MRY)


AVNS Assets (MRY)


Total Assets

$1.15B

Total Liabilities

$325.70M

Total Investments

$0

AVNS Income (MRY)


Revenue

$687.80M

Net Income

-$392.10M

Operating Expense

$781.40M

AVNS Cash Flow (MRY)


CF Operations

$100.70M

CF Investing

-$27.50M

CF Financing

-$49.10M

AVNS Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$1,154,200,000 (-31.80%)

$1,692,400,000 (-5.29%)

$1,786,900,000 (11.43%)

$1,603,600,000 (-4.14%)

Assets Current

$393,400,000 (-19.22%)

$487,000,000 (-21.97%)

$624,100,000 (45.95%)

$427,600,000 (-8.48%)

Assets Non-Current

$760,800,000 (-36.88%)

$1,205,400,000 (3.66%)

$1,162,800,000 (-1.12%)

$1,176,000,000 (-2.46%)

Goodwill & Intangible Assets

$567,900,000 (-45.16%)

$1,035,600,000 (4.13%)

$994,500,000 (5.48%)

$942,800,000 (-1.81%)

Shareholders Equity

$828,500,000 (-32.99%)

$1,236,300,000 (-4.25%)

$1,291,200,000 (1.62%)

$1,270,600,000 (1.12%)

Property Plant & Equipment Net

$144,800,000 (0.56%)

$144,000,000 (-1.44%)

$146,100,000 (-29.32%)

$206,700,000 (-7.56%)

Cash & Equivalents

$107,700,000 (22.81%)

$87,700,000 (-31.32%)

$127,700,000 (7.76%)

$118,500,000 (6.28%)

Accumulated Other Comprehensive Income

-$44,600,000 (-65.19%)

-$27,000,000 (24.58%)

-$35,800,000 (-5.92%)

-$33,800,000 (-20.28%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$138,800,000 (-14.95%)

$163,200,000 (23.36%)

$132,300,000 (-16.95%)

$159,300,000 (-5.68%)

Trade & Non-Trade Receivables

$132,800,000 (-7.00%)

$142,800,000 (-14.95%)

$167,900,000 (27.97%)

$131,200,000 (20.81%)

Trade & Non-Trade Payables

$54,300,000 (-3.55%)

$56,300,000 (-17.08%)

$67,900,000 (20.39%)

$56,400,000 (-16.57%)

Accumulated Retained Earnings (Deficit)

-$707,000,000 (-124.52%)

-$314,900,000 (-24.42%)

-$253,100,000 (16.63%)

-$303,600,000 (3.77%)

Tax Assets

$24,900,000 (283.08%)

$6,500,000 (41.30%)

$4,600,000 (-54.00%)

$10,000,000 (-85.57%)

Tax Liabilities

$5,500,000 (-76.89%)

$23,800,000 (-6.30%)

$25,400,000 (113.45%)

$11,900,000 (108.77%)

Total Debt

$170,200,000 (-18.60%)

$209,100,000 (-24.51%)

$277,000,000 (47.73%)

$187,500,000 (-24.64%)

Debt Current

$20,300,000 (-5.14%)

$21,400,000 (17.58%)

$18,200,000 (23.81%)

$14,700,000 (-5.16%)

Debt Non-Current

$149,900,000 (-20.14%)

$187,700,000 (-27.47%)

$258,800,000 (49.77%)

$172,800,000 (-25.93%)

Total Liabilities

$325,700,000 (-28.59%)

$456,100,000 (-7.99%)

$495,700,000 (48.86%)

$333,000,000 (-20.01%)

Liabilities Current

$165,900,000 (-29.28%)

$234,600,000 (22.83%)

$191,000,000 (37.21%)

$139,200,000 (-16.30%)

Liabilities Non-Current

$159,800,000 (-27.86%)

$221,500,000 (-27.31%)

$304,700,000 (57.22%)

$193,800,000 (-22.48%)

AVNS Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$687,800,000 (2.15%)

$673,300,000 (-1.58%)

$684,100,000 (16.54%)

$587,000,000 (-17.88%)

Cost of Revenue

$306,500,000 (4.39%)

$293,600,000 (1.28%)

$289,900,000 (0.73%)

$287,800,000 (-16.31%)

Selling General & Administrative Expense

$318,500,000 (-4.93%)

$335,000,000 (2.60%)

$326,500,000 (14.44%)

$285,300,000 (-14.22%)

Research & Development Expense

$26,200,000 (-3.68%)

$27,200,000 (-6.85%)

$29,200,000 (-4.58%)

$30,600,000 (-12.32%)

Operating Expenses

$781,400,000 (115.74%)

$362,200,000 (1.83%)

$355,700,000 (12.60%)

$315,900,000 (-14.04%)

Interest Expense

$12,200,000 (-18.67%)

$15,000,000 (50.00%)

$10,000,000 (203.03%)

$3,300,000 (-78.85%)

Income Tax Expense

-$17,000,000 (-950.00%)

$2,000,000 (-61.54%)

$5,200,000 (146.43%)

-$11,200,000 (66.96%)

Net Loss Income from Discontinued Operations

$5,800,000 (-88.82%)

$51,900,000 (278.97%)

-$29,000,000 (22.04%)

-$37,200,000 (0%)

Consolidated Income

-$392,100,000 (-534.47%)

-$61,800,000 (-222.38%)

$50,500,000 (701.59%)

$6,300,000 (121.72%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$392,100,000 (-534.47%)

-$61,800,000 (-222.38%)

$50,500,000 (701.59%)

$6,300,000 (121.72%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$392,100,000 (-534.47%)

-$61,800,000 (-222.38%)

$50,500,000 (701.59%)

$6,300,000 (121.72%)

Weighted Average Shares

$45,956,997 (-1.01%)

$46,425,569 (-0.15%)

$46,497,608 (-3.51%)

$48,186,573 (0.74%)

Weighted Average Shares Diluted

-

-

-

-

Earning Before Interest & Taxes (EBIT)

-$396,900,000 (-785.94%)

-$44,800,000 (-168.19%)

$65,700,000 (4206.25%)

-$1,600,000 (96.62%)

Gross Profit

$381,300,000 (0.42%)

$379,700,000 (-3.68%)

$394,200,000 (31.75%)

$299,200,000 (-19.33%)

Operating Income

-$400,100,000 (-2386.29%)

$17,500,000 (-54.55%)

$38,500,000 (330.54%)

-$16,700,000 (-591.18%)

AVNS Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$27,500,000 (-227.31%)

$21,600,000 (115.95%)

-$135,400,000 (-544.76%)

-$21,000,000 (13.22%)

Net Cash Flow from Financing

-$49,100,000 (47.88%)

-$94,200,000 (-266.14%)

$56,700,000 (202.53%)

-$55,300,000 (21.00%)

Net Cash Flow from Operations

$100,700,000 (210.80%)

$32,400,000 (-64.36%)

$90,900,000 (4.12%)

$87,300,000 (3592.00%)

Net Cash Flow / Change in Cash & Cash Equivalents

$20,000,000 (150.00%)

-$40,000,000 (-534.78%)

$9,200,000 (31.43%)

$7,000,000 (107.46%)

Net Cash Flow - Business Acquisitions and Disposals

$2,100,000 (-94.67%)

$39,400,000 (133.94%)

-$116,100,000 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$11,800,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$17,800,000 (0.00%)

-$17,800,000 (7.77%)

-$19,300,000 (8.10%)

-$21,000,000 (-3.96%)

Issuance (Repayment) of Debt Securities

-$33,600,000 (48.07%)

-$64,700,000 (-164.38%)

$100,500,000 (301.00%)

-$50,000,000 (28.37%)

Issuance (Purchase) of Equity Shares

-$11,700,000 (34.27%)

-$17,800,000 (59.36%)

-$43,800,000 (-726.42%)

-$5,300,000 (-312.00%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$4,100,000 (-2150.00%)

$200,000 (106.67%)

-$3,000,000 (25.00%)

-$4,000,000 (-237.93%)

Share Based Compensation

$13,800,000 (-12.66%)

$15,800,000 (-0.63%)

$15,900,000 (20.45%)

$13,200,000 (9.09%)

Depreciation Amortization & Accretion

$45,500,000 (-1.30%)

$46,100,000 (-3.35%)

$47,700,000 (24.54%)

$38,300,000 (-10.72%)

AVNS Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

55.40% (-1.77%)

56.40% (-2.08%)

57.60% (12.94%)

51.00% (-1.73%)

Profit Margin

-57.00% (-519.57%)

-9.20% (-224.32%)

7.40% (572.73%)

1.10% (126.83%)

EBITDA Margin

-51.10% (-25650.00%)

0.20% (-98.80%)

16.60% (163.49%)

6.30% (1150.00%)

Return on Average Equity (ROAE)

-34.80% (-596.00%)

-5.00% (-225.00%)

4.00% (700.00%)

0.50% (121.74%)

Return on Average Assets (ROAA)

-25.60% (-611.11%)

-3.60% (-224.14%)

2.90% (625.00%)

0.40% (123.53%)

Return on Sales (ROS)

-57.70% (-761.19%)

-6.70% (-169.79%)

9.60% (3300.00%)

-0.30% (95.45%)

Return on Invested Capital (ROIC)

-74.00% (-988.24%)

-6.80% (-174.73%)

9.10% (4650.00%)

-0.20% (96.88%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-1.87 (89.02%)

-16.99 (-167.82%)

25.06 (-90.60%)

266.69 (454.58%)

Price to Sales Ratio (P/S)

1.06 (-31.22%)

1.55 (-15.88%)

1.84 (-35.38%)

2.85 (-7.30%)

Price to Book Ratio (P/B)

0.88 (4.87%)

0.84 (-13.55%)

0.97 (-25.93%)

1.31 (-24.73%)

Debt to Equity Ratio (D/E)

0.39 (6.50%)

0.37 (-3.91%)

0.38 (46.56%)

0.26 (-20.85%)

Earnings Per Share (EPS)

-8.53 (-546.21%)

-1.32 (-222.22%)

1.08 (730.77%)

0.13 (121.31%)

Sales Per Share (SPS)

14.97 (3.19%)

14.5 (-1.43%)

14.71 (20.78%)

12.18 (-18.48%)

Free Cash Flow Per Share (FCFPS)

1.8 (474.52%)

0.31 (-79.61%)

1.54 (11.92%)

1.38 (389.68%)

Book Value Per Share (BVPS)

18.03 (-32.30%)

26.63 (-4.10%)

27.77 (5.31%)

26.37 (0.38%)

Tangible Assets Book Value Per Share (TABVPS)

12.76 (-9.82%)

14.15 (-16.99%)

17.04 (24.28%)

13.71 (-7.95%)

Enterprise Value Over EBIT (EV/EBIT)

-2 (92.86%)

-28 (-227.27%)

22 (101.98%)

-1,112 (-2169.39%)

Enterprise Value Over EBITDA (EV/EBITDA)

-2.4 (-100.25%)

954.56 (7389.08%)

12.75 (-73.70%)

48.46 (109.13%)

Asset Turnover

0.45 (13.67%)

0.4 (2.33%)

0.39 (7.52%)

0.36 (-12.22%)

Current Ratio

2.37 (14.21%)

2.08 (-36.47%)

3.27 (6.38%)

3.07 (9.36%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

$82,900,000 (467.81%)

$14,600,000 (-79.61%)

$71,600,000 (7.99%)

$66,300,000 (392.07%)

Enterprise Value (EV)

$844,835,392 (-31.92%)

$1,240,925,513 (-14.15%)

$1,445,425,272 (-18.73%)

$1,778,628,486 (-23.82%)

Earnings Before Tax (EBT)

-$409,100,000 (-584.11%)

-$59,800,000 (-207.36%)

$55,700,000 (1236.73%)

-$4,900,000 (92.21%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$351,400,000 (-27130.77%)

$1,300,000 (-98.85%)

$113,400,000 (208.99%)

$36,700,000 (934.09%)

Invested Capital

$482,900,000 (-11.17%)

$543,600,000 (-27.59%)

$750,700,000 (27.11%)

$590,600,000 (-13.60%)

Working Capital

$227,500,000 (-9.87%)

$252,400,000 (-41.72%)

$433,100,000 (50.17%)

$288,400,000 (-4.15%)

Tangible Asset Value

$586,300,000 (-10.73%)

$656,800,000 (-17.11%)

$792,400,000 (19.92%)

$660,800,000 (-7.27%)

Market Capitalization

$731,635,392 (-29.74%)

$1,041,325,513 (-17.24%)

$1,258,225,272 (-24.69%)

$1,670,628,486 (-23.87%)

Average Equity

$1,127,025,000 (-9.69%)

$1,247,975,000 (-1.40%)

$1,265,700,000 (-0.37%)

$1,270,350,000 (0.33%)

Average Assets

$1,532,375,000 (-10.11%)

$1,704,725,000 (-3.71%)

$1,770,350,000 (8.38%)

$1,633,400,000 (-6.55%)

Invested Capital Average

$536,650,000 (-18.28%)

$656,675,000 (-9.45%)

$725,200,000 (11.60%)

$649,800,000 (-11.71%)

Shares

45,956,997 (-1.01%)

46,425,569 (-0.15%)

46,497,608 (-3.51%)

48,186,573 (0.74%)